Growing Concern Over Private Healthcare Costs
Health rights groups are calling for stronger regulation of private hospitals in India, arguing that patients often face high and unpredictable bills for treatments, medicines and medical consumables. The demand comes amid renewed scrutiny of healthcare pricing and medicine mark ups.
Calls for Transparent Hospital Rates
The Jan Swasthya Abhiyan and the Working Group on Access to Medicines and Treatment have urged the government to regulate charges for procedures and services at private hospitals.
They argue that patients should know the likely cost of treatment before agreeing to undergo a procedure, particularly when there is little scope for negotiating hospital rates.
Clinical Establishments Act Still a Concern
The groups have also highlighted the limited implementation of the Clinical Establishments Act, 2010, which provides a framework for regulating clinical establishments and envisages government-determined ranges for charges.
According to the groups, the absence of effective implementation has left patients without a consistent nationwide system for controlling private healthcare costs.
Medicine Mark-Ups Under Scrutiny
Medicine pricing has emerged as another major concern. The Supreme Court recently questioned a case in which a cancer medicine supplied at around ₹2,700 was reportedly sold with an MRP of about ₹27,000.
Health groups are seeking limits on trade margins for medicines, medical devices and consumables to prevent excessive mark-ups.
Hospitals Defend the Larger Cost Structure
Hospital industry representatives have argued that medicine prices should not be assessed separately from the wider cost of healthcare delivery. They point to expenses involving doctors, nurses, diagnostics, infrastructure, compliance and patient monitoring.
The Association of Healthcare Providers of India has called for an evidence-based approach that considers the complete healthcare value chain rather than applying a single margin rule.
Why Patients Need Greater Protection
The debate highlights a difficult balance between keeping healthcare affordable and ensuring hospitals can maintain quality infrastructure and services.
For patients, greater transparency in bills, clearer pricing and stronger regulation could make it easier to understand healthcare costs and avoid unexpected financial burdens.
What Could Change?
The growing pressure from health groups, patient advocates and judicial scrutiny could push policymakers to revisit hospital pricing and medicine margins.
A clearer regulatory framework could help create more predictable costs while ensuring that private healthcare remains financially sustainable and medically safe.
